We are live on ! Find out more
BG

Bellevue Group Portfolio holdings

AUM $4.2B
1-Year Est. Return 54.85%
This Fund
S&P 500
This Quarter Est. Return
+9.35%
1 Year Est. Return
+54.85%
3 Year Est. Return
+140.3%
5 Year Est. Return
+171.01%
10 Year Est. Return
+915.55%
AUM
$846M
AUM Growth
+$95.3M
Cap. Flow
+$37.1M
Cap. Flow %
4.39%
Top 10 Hldgs %
28.99%
Holding
143
New
11
Increased
56
Reduced
23
Closed
11

Top Buys

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$7.11M
2
IART icon
Integra LifeSciences
IART
+$6.94M
3
CI icon
Cigna
CI
+$6.83M
4
ALKS icon
Alkermes
ALKS
+$5.7M
5
IQV icon
IQVIA
IQV
+$5.62M

Top Sells

Rank Stock Value
1
AKRX
Akorn Inc
AKRX
+$11.9M
2
CNC icon
Centene
CNC
+$9.33M
3
INCY icon
Incyte
INCY
+$8.09M
4
LGND icon
Ligand Pharmaceuticals
LGND
+$6.18M
5
ALR
Alere Inc
ALR
+$5.78M

Sector Composition

Rank Sector Weight
1 Healthcare 92.73%
2 Financials 0.93%
3 Industrials 0.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HIND
126
Vyome Holdings
HIND
$15.1M
– –
0
– –
WBMD
127
DELISTED
WebMD Health Corp.
WBMD
$434K 0.05%
7,400
– –
CLDX icon
128
Celldex Therapeutics
CLDX
$2.77B
$395K 0.05%
10,667
– –
ALDR
129
DELISTED
Alder Biopharmaceuticals
ALDR
$378K 0.04%
33,000
– –
ESPR
130
DELISTED
Esperion Therapeutics
ESPR
$370K 0.04%
8,000
-24,000
-75% -$883K
MYGN icon
131
Myriad Genetics
MYGN
$584M
$336K 0.04%
13,000
– –
AAC
132
DELISTED
AAC Holdings
AAC
$312K 0.04%
45,000
– –
BMY icon
133
Bristol-Myers Squibb
BMY
$124B
– –
-23,000
Closed -$1.25M
CERS icon
134
Cerus
CERS
$627M
– –
-30,000
Closed -$134K
CHRS icon
135
Coherus Oncology
CHRS
$216M
– –
-175,000
Closed -$3.7M
NVAX icon
136
Novavax
NVAX
$1.35B
– –
-16,250
Closed -$416K
LFWD icon
137
ReWalk Robotics
LFWD
$22.3M
– –
-95
Closed -$420K
AKRX
138
DELISTED
Akorn Inc
AKRX
– –
-494,600
Closed -$11.9M
ACHN
139
DELISTED
Achillion Pharmaceuticals
ACHN
– –
-99,000
Closed -$417K
ALR
140
DELISTED
Alere Inc
ALR
– –
-145,363
Closed -$5.78M
NVDQ
141
DELISTED
Novadaq Technologies Inc.
NVDQ
– –
-150,000
Closed -$1.17M
ZLTQ
142
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
– –
-22,000
Closed -$1.22M
QGENF
143
DELISTED
QIAGEN NV
QGENF
– –
-79,444
Closed -$2.3M
2 3 4 5
6

Similar funds

WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.2B AUM 18.37% 1-Year Est. Return
AC
AlphaCore Capital La Jolla, California $4.22B AUM 21.28% 1-Year Est. Return
HIP
HUB Investment Partners Austin, Texas $4.18B AUM 24.76% 1-Year Est. Return
DT
DV Trading Chicago, Illinois $4.22B AUM
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.23B AUM 20.9% 1-Year Est. Return
BT
Banque Transatlantique Paris, France $4.17B AUM 28.5% 1-Year Est. Return
NCM
Nearwater Capital Markets Dublin 4, Dublin, Ireland $4.24B AUM 66.03% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return

Bellevue Group's Q2 2017 Portfolio in Review

As of Q2 2017, Bellevue Group held 143 positions worth $846M, up 13% from $750M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Bellevue Group deployed $37.1M of net new capital in Q2 2017, opening 11 new positions and adding to 56 existing holdings. Its largest new stake was IQVIA: 66,520 shares worth $5.95M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 92% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Centene, an estimated $9.33M trimmed.

  • Bellevue Group's largest Q2 2017 buy was IQVIA: 66,520 shares worth $5.95M.
  • Bellevue Group added most to Edwards Lifesciences in Q2 2017, an estimated $7.11M increase.
  • Bellevue Group's biggest Q2 2017 reduction was Centene, cutting an estimated $9.33M.
  • Bellevue Group fully exited Akorn Inc in Q2 2017, selling an estimated $11.9M.
  • Bellevue Group's ten largest holdings make up 29% of its $846M portfolio in Q2 2017.
  • Bellevue Group opened 11 new positions and closed 11 in Q2 2017.
  • Bellevue Group's portfolio value rose 13% quarter-over-quarter to $846M.

Based on Bellevue Group's 13F filing for Q2 2017, filed 14 Aug 2017.